| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |